Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 259 participants.

Also called NCT03951207

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 259 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03951207
Other papers using this trial's data
  • Randomized, multicenter, parallel, open, phase 4 study to compare the efficacy and safety of rosuvastatin/amlodipine polypill versus atorvastatin/amlodipine polypill in hypertension patient with dyslipidemia Journal of clinical hypertension (Greenwich, Conn.), 2023-09 DOI, PubMed 37584254, PMC10497028 In the PMC Open Access subset under CC BY-NC-ND.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
South Korea (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03951207. Randomized; no masking; primary purpose treatment. Start 2019-05-30 (actual); primary completion 2021-09-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Rosuvastatin/Amlodipine vs Atorvastatin/Amlodipine in Hypertension Patient With Dyslipidemia
Acronym
CORONA
Condition
Dyslipidemias
Condition
Hypertension
Intervention (Drug)
Rosuampin 10/5mg
Intervention (Drug)
Rosuampin 20/5mg
Intervention (Drug)
Amlodipine/Atorvastatin 5/20mg
Lead sponsor
Yuhan Corporation (class: industry)

Record details

Record id
cardio:ct-nct03951207
Content hash
9ec9df8a967095861cbc9209babdc8f83b2e2ed551d50f25d4e755aede143dc5